Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Pfizer

US approves first vaccine for RSV after decades of attempts

The US has approved the first vaccine for RSV, shots to protect older adults

The Independent UK

Pfizer Reports Dramatic Declines — But It's Not As Bad As Wall Street Expected

Pfizer reported double-digit declines across its first-quarter metrics, but beat analysts' expectations. Pfizer stock fell Tuesday.

Investors Business Daily

Dow Jones Slides On Key Economic Data. Fed Meeting Begins, While Tesla Rallies On Price Hikes.

The Dow Jones sold off 300 points Tuesday after key economic data, as the Fed's policy meeting begins. Tesla stock rallied on price hikes.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Attorney General Ken Paxton to investigate COVID-19 vaccine makers

Long an opponent of vaccine and mask mandates, the Republican said pharmaceutical companies may have misrepresented data. Pfizer strongly disagrees.

The Texas Tribune

Pfizer, BioNTech Propose EU Pays Half for Each Cancelled COVID Dose

Pfizer Inc and BioNTech's new proposal to the European Union, amid a glut of COVID-19 shots, includes a provision for member states to pay half price, or about 10 euros ($11), for each of about 70 million cancelled doses, the Financial Times reported on Sunday. The revised contract would allow…

Asharq Al-Awsat

Could Government Drug-Price Negotiations Sound The Death Knell For Biotech Stocks?

Industry analysts warn that a groundbreaking change in how Medicare buys drugs threatens industry growth, profits — and maybe patient care.

Investors Business Daily

People urged to start wearing masks and testing thanks to new Covid strain

Experts say it is up to individuals to help stop the spread of the disease

Wales Online

Read news from The Economist, FT, and more,
with one subscription

UK and Europe are falling behind US and China in biotech, says AstraZeneca boss

Pascal Soriot says decline in startups across Europe differs markedly from ‘explosion’ of firms and clinical trials in China

The Guardian - UK

What lessons have we learned from the COVID pandemic?

The nonpartisan Covid Crisis Group has released its investigative report, titled "Lessons from the Covid War: An Investigative Report." This is what it found.

WEKU

AstraZeneca overtakes Pfizer as crunch week for UK pharma looms

Driven by a revamped drug portfolio, AstraZeneca is expected to report revenues of $10.7bn in its latest quarterly results

The Guardian - UK

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK

Novavax Plummets On Downgrade: Is It The Covid Engine That Couldn't?

Novavax has a solid platform but continues to face a $700 million litigation headwind, an analyst said Thursday as he downgraded NVAX stock.

Investors Business Daily

CDC has approved spring COVID booster for some. Do you need it?

Another COVID-19 booster shot is on the way as federal health officials look to further augment protection for those at greater risk of developing severe disease.

Los Angeles Times

Extra spring COVID booster cleared for certain Americans

Certain Americans at high risk from COVID-19 can get an extra vaccine booster this spring

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

These 10 Crummy Stocks Already Cost Investors $300 Billion

What's worse than missing out on the five stocks driving the entire S&P 500 this year? Owning the ones that are dragging it down.

Investors Business Daily

Merck Nabs Prometheus Bio For $10.8 Billion As Keytruda Patent Expirations Loom

Merck is acquiring Prometheus Bio in a well-timed $10.8 billion deal ahead of Keytruda's patent loss. The news sent RXDX stock flying Monday.

Evening Standard

Autumn Covid booster 2023: Who is eligible for another jab?

If invited, you will receive a booster dose of a Covid-19 vaccine made by Pfizer, Moderna, or Sanofi

The Week

Sanofi: the new protein-based Covid vaccine to be used in the UK

The University of Edinburgh’s Neil Mabbott on the vaccine technology being used for Covid booster jabs from this month.

Get all your
news in one place.

100’s of premium titles.
One news app.

Wales Online

5million people called on to get another Covid jab from today

Eligible people include those aged 75 and over, and anyone aged five and over who has a weakened immune system

The Independent UK

Millions eligible for Covid jab as spring booster campaign begins

Around five million people in total are eligible for a booster until the end of June.

Newsroom.co.nz

Protect yourself from side effects just by reading this article

Research shows that knowing about the nocebo effect – the 'evil twin' of the placebo effect – means you are less likely to experience negative side effects of drugs or treatments, says Dr Kate MacKrill

Wales Online

Everything we know about new Sanofi Covid vaccine now being used in UK

The vaccine being used in the Spring booster campaign works in a different way to previous jabs

The Conversation

Sanofi vaccine: what to know about this protein-based COVID booster being offered in the UK

In the UK a spring booster campaign has recently begun, offering an additional vaccine to people at highest risk from COVID. Between April and June 2023 people aged over 75, residents in care homes and children and adults aged five and up with weakened immune systems will be invited to…

The Conversation

Pregnant this winter? Here's how to prepare for COVID and get vaccinated

With the days becoming noticeably shorter, winter is on its way in the Southern Hemisphere.

The Independent UK

Pharmaceutical executives challenge Texas court’s abortion pill ruling

Gilead Sciences and Pfizer join amicus brief

1 … 19 20 21 22

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

the Southern Hemisphere

33 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.